Page 9 - Investor Relations News

• Record fourth quarter and full fiscal year revenue of $45.8 million and $173.1 million, respectively
• Service segment continued to deliver revenue growth of 2.9% and 10.7% in the fourth quarter and fiscal 2020, respectively, despite COVID-19 impact in the latter half of the fourth quarter
• Service segment gross margin expanded 120 basis points to 28.9% in the fourth quarter; up 40 basis points for the fiscal year
• Achieved record net income of $8.1 million, or $1.08 per diluted share, in fiscal 2020

ROCHESTER, NY, May 6, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its fourth quarter and full fiscal year 2020 results after the close of financial markets on Tuesday, May 19, 2020.

ROCHESTER, NY, March 30, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and valueadded distributor of professional grade handheld test, measurement and control instrumentation, provided an update on its operations and actions to address the COVID-19 pandemic.

LOS ANGELES, CA / ACCESSWIRE / February 26, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today announced that Michael J. Tschiderer, Chief Financial Officer, will present at the LD Micro Virtual Investor Conference on Tuesday, March 3, 2020.

Adds new Service capabilities, expands market penetration to the life sciences market and strengthens Distribution sales platform

ROCHESTER, NY, January 22, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2020 results after the close of financial markets on Tuesday, February 4, 2020.

• Record third quarter consolidated revenue of $43.2 million in fiscal 2020
• Solid Service segment organic revenue growth of 7.8% reflects continued market expansion, including within the highly regulated life sciences market
• Distribution segment revenue growth of 3.5%
• Generated $8.2 million in cash from fiscal year-to-date operations, up 13.6%

ROCHESTER, NY, January 22, 2020 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its third quarter fiscal year 2020 results after the close of financial markets on Tuesday, February 4, 2020.

ROCHESTER, NY, October 28, 2019 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it has appointed Oksana S. “Sandy” Dominach as an independent director to its Board. Ms. Dominach brings more than 32 years of experience and expertise in financial strategy, risk management and treasury, as well as over ten years of experience participating on a variety of public and non-for-profit boards. She is currently the Senior Vice President & Treasurer at Constellation Brands, Inc. (NYSE: STZ), a leading international producer and marketer of beer, wine and spirits.

• Service segment revenue increased 18.1% with strong Service organic growth of 15.1%
• Productivity initiatives developing early traction as Service segment gross margin expanded 140 basis points; consolidated gross profit margin increased 150 basis points
• Consolidated operating income grew more than 40% on total revenue growth of 7.4%
• Achieved net income of $2.4 million and diluted earnings per share of $0.32, up $0.12

ROCHESTER, NY, October 9, 2019 – Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2020 results after the close of financial markets on Tuesday, October 22, 2019.